Note: Ingredients listed on restricted chemical lists
General Information
Revision date
2020-01-20
Product name
NEXIUM FOR ORAL SUSPENSION
Product Synonyms
Pellets for Esomeprazole sachets for Delayed-Release Oral Suspension (2.5mg, 5mg,10mg, 20 and 40mg)
1.2.1 Relevant identified uses
Symptomatic treatment of gastro-oesophageal reflux disease (GERD)
supplier name
ASTRAZENECA PTY LTD
Icons in SDS
Company Information
company name
ASTRAZENECA PTY LTD
e-mail address of the competent person responsible for the Safety Data Sheet
SafetyDataSheets.AlderleyPark@astrazeneca.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H317
Hazard statements
Code
Statements
H317
May cause an allergic skin reaction
Section 2
2.1 Classification of the substance or mixture
Skin sensitisation Category 1
Signal word
Warning
Hazard statements
H317 May cause an allergic skin reaction.
Prevention
P261 Avoid breathing dust/ fume/ gas/ mist/ vapours/ spray. P272 Contaminated work clothing should not be allowed out of the workplace. P280 Wear protective gloves.
Response
P302 + P352 IF ON SKIN: Wash with plenty of soap and water. P333 + P313 If skin irritation or rash occurs: Get medical advice/ attention.
Disposal
P501 Dispose of contents/ container to an approved waste disposal plant.
Other hazards which do not result in classification
May cause irritation to skin, eyes and respiratory system. The product may form flammable dust clouds in air, if dust from pellets is allowed to accumulate and if it is dispersed.
